Glenmark's $30M Drug Price-Fixing Deal Gets Final OK
A Connecticut federal judge has granted final approval to a $29.6 million settlement between dozens of states and Glenmark Pharmaceuticals that resolves claims accusing the company of conspiring with competitors to...To view the full article, register now.
Already a subscriber? Click here to view full article